BioAdaptives, Inc.
BDPT
$0.0257
$0.00124.90%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 12.12% | -26.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 13.37% | -26.15% | |||
| Operating Income | -12.08% | 26.15% | |||
| Income Before Tax | 19.89% | 46.99% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 19.89% | 46.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 19.89% | 46.99% | |||
| EBIT | -12.08% | 26.15% | |||
| EBITDA | -12.06% | 26.27% | |||
| EPS Basic | 23.85% | 41.87% | |||
| Normalized Basic EPS | 23.53% | 41.88% | |||
| EPS Diluted | 23.85% | 41.87% | |||
| Normalized Diluted EPS | 23.53% | 41.88% | |||
| Average Basic Shares Outstanding | 5.36% | -8.70% | |||
| Average Diluted Shares Outstanding | 5.36% | -8.70% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||